Article
FDA approves new drug lecanemab that appears to slow early, mild Alzheimer's
Rating:
0.0
Views:
41
Likes:
1
Library:
1
Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer's drug that appears to slow the disease.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value